SSE Ticker: 603127

Joinn Laboratories (China) Co., Ltd.

昭衍新药

Authorized Representative: 冯宇霞

Board: Main A

Industry Classification: Research & Development

Experimental monkey trapped in time-Titanium Media Official Website

Post date May 20, 2022 — 16:55 Post Lock

"I don't think it's unusual for a monkey to rise to 200,000"

Post date May 20, 2022 — 16:55 Post Lock

"Experimental Monkey" interface news trapped in time JMedia

Post date May 20, 2022 — 16:41 Post Lock

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

Post date May 13, 2022 — 20:12 Post Lock

Behind the "robbing monkeys" war: free-range farmers who have no intention to expand, and CROs who are "choked" by the lack of monkeys

Post date May 12, 2022 — 20:16 Post Lock

Changxin Healthcare Hybrid (LOF) C Net Worth Up 3.26% LOF

Post date May 12, 2022 — 07:54 Post Lock

Morgan Stanley Health Industry Mixed C Net Worth Up 3.81%

Post date May 12, 2022 — 07:46 Post Lock

Hong Kong stocks CXO concept stocks continue to rise

Post date May 11, 2022 — 12:30 Post Lock

[Exploration of the outlet · CXO] The high-speed growth of construction in progress after deducting non-profits in the first quarter helped AH shares "stand up"

Post date May 11, 2022 — 12:25 Post Lock

Hexun SGI company's domestic animal model industry's leading company's benefits highlight the South Model Biology SGI's 93 high-value company's ability to manage money needs to be improved_Stock News_Market_Zhongjin Online

Post date May 10, 2022 — 19:20 Post Lock

Bank of China Securities: CXO's booming growth continues, and investment has entered a period of careful selection

Post date May 10, 2022 — 10:15 Post Lock

BOC Securities: CXO's high boom growth continues, and investment has entered a period of careful selection of CXO_Sina Finance_Sina Network

Post date May 10, 2022 — 10:12 Post Lock

Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network

Post date May 9, 2022 — 08:47 Post Lock

Summary of the 2021 annual report and 2022 first quarter report of the medical sector of Sinolink Securities: The overall performance is clear, and it still maintains a strong growth ability! -Funds Financial Sector

Post date May 5, 2022 — 16:30 Post Lock

A-share lunch review: Shanghai index rose 1.11% in half a day, and the turnover of Ningde era exceeded 17 billion yuan

Post date May 5, 2022 — 11:56 Post Lock

The concept of CRO fluctuated and fell, many stocks fell more than 5%

Post date May 5, 2022 — 10:48 Post Lock

Trends of the main institutions in the first quarter: the "ace portfolio" of the social security fund insists on growth; the pension fund grabs 47 shares! _Funds_Financial Channel Home_Financial Network CAIJING.COM.CN

Post date May 5, 2022 — 09:35 Post Lock

Trends of the main institutions in the first quarter: the "ace portfolio" of the social security fund insists on growth; the pension fund grabs 47 shares! _Finance Net

Post date May 5, 2022 — 09:20 Post Lock

Trends of the main institutions in the first quarter: the "ace portfolio" of the social security fund insists on growth; the pension fund grabs 47 shares!

Post date May 5, 2022 — 08:35 Post Lock

Pacific gives Zhaoyan New Drug a Buy rating, Q1 results exceed expectations, new orders maintain high growth rate – yqqlm

Post date April 30, 2022 — 15:34 Post Lock

Want to see more data? Registered subscribers can see all the data.